Clinical Trials Logo

Sleep Apnea Syndromes clinical trials

View clinical trials related to Sleep Apnea Syndromes.

Filter by:

NCT ID: NCT04631107 Completed - Clinical trials for Obstructive Sleep Apnea

AD109 Dose Finding in Mild to Moderate OSA

Start date: December 22, 2020
Phase: Phase 2
Study type: Interventional

This is a randomized, 3-period, placebo-controlled, crossover, phase 2 clinical study to examine the efficacy and safety of 2 doses of AD109 vs placebo in patients with mild obstructive sleep apnea.

NCT ID: NCT04630639 Withdrawn - Clinical trials for Sleep Apnea, Obstructive

Sparkle Respiratory Effort Validation

Start date: March 2021
Phase: N/A
Study type: Interventional

This study has been developed in order to demonstrate the validity of the Sparkle respiratory effort signal.

NCT ID: NCT04630535 Recruiting - Clinical trials for Obstructive Sleep Apnea

OSA as a Remote Ischemic Preconditioning in Vascular Surgery

Start date: November 1, 2020
Phase:
Study type: Observational

Ischemia and reperfusion (I/R) injury during abdominal aortic aneurysm (AAA) repair is inevitable and may lead to postoperative multi-organ failure. Remote ischemic preconditioning (short periods of ischemia in anticipation of longer period of ischemia) may act protectively against ischemia. Studies of ischemic preconditioning in patients with AAA are conflicting. Obstructive sleep apnea (OSA) is a sleep disordered breathing syndrome which may have a protective effect against ischemia. The investigators hypothesize that I/R injury will be less pronounced in patients who have OSA and that the extent of I/R injury will inversely correlate with OSA severity. Accordingly, the aim of this study is to compare postoperative complications and markers of I/R in patients undergoing elective AAA repair who do and do not have OSA.

NCT ID: NCT04624815 Terminated - Asthma Clinical Trials

Factors Issued From Functional Exploration Associated to SAHOS in Asthmatic Children

SASTHMA
Start date: November 20, 2020
Phase:
Study type: Observational

There is an increase in the prevalence of obstructive apnea-hypopnea syndrome (OSA) in children for which the pathophysiological explanation is unknown. The main objective is to compare pharyngeal collapsibility in asthmatic children with SHS score > 2.75 or ≤ 2.75 (OSA prediction score validated in French). Secondary objectives: Compare pharyngeal size, tracheal size, loop gain and its components (controller, plant), lung volumes and expired and nasal NO in asthmatic children with SHS score > 2.75 or ≤ 2.75. The bias due to the possible existence of an alveolar hyperventilation syndrome associated with asthma will be taken into account.

NCT ID: NCT04621513 Recruiting - Clinical trials for Pediatric Sleep Apnea

Collaborative Care Model for Allergic Rhinitis With Obstructive Sleep Apnea From Prevention to Treatment.

Start date: July 29, 2020
Phase: N/A
Study type: Interventional

In this project,the investigators aim to establish a Collaborative Care Model of TCM and Western Medicine to improve the quality of life and symptoms of AR with OSA children and educate care-givers diet and massage information to improve self-care ability and alleviate anxiety for parents. In addition, the investigators will use portable oxymeter to detect the change of SpO2 and respiratory arousal index daily at home and evaluate sensitivity and specificity of portable oxymeter device applied in OSA. The investigators want to give holistic health care for participants and care-givers by this project. In addition, the investigators will build a training environment to provide medical education and training opportunity to teach medical students and clinician the knowledge of pediatric allergic rhinitis and obstructive sleep apnea by caring patients and learning from clinical cases.

NCT ID: NCT04621032 Completed - Clinical trials for Obstructive Sleep Apnea

Obstructive Sleep Apnea Destabilizes Myocardial Repolarization Homogeneity

Start date: September 1, 2016
Phase:
Study type: Observational [Patient Registry]

Literature shows that patients with obesity and Obstructive Sleep Apnea (OSA), both occurring independently, are more likely to develop cardiovascular diseases and sudden cardiac death (SCD). Assuming that ventricular depolarization is more stable than repolarization then QT interval parameters may be used for heart muscle repolarization assessment for those groups of patients. There were 121 patients included in the study, both - women and men, aging from 35-65 with visceral obesity. Only healthy patients were included - the ones who were not treated for any chronic disease, taking QT elongating drugs, or were not treated with Continuous Positive Airway Pressure (CPAP) therapy at that time.

NCT ID: NCT04618991 Recruiting - Clinical trials for Obstructive Sleep Apnea

Assessment of the Impact on the Quality of Life of Surgically Assisted Maxillary Expansion in Adult Patients Followed for Obstructive Sleep Apnea Syndrome

QUAVIMAX
Start date: March 15, 2021
Phase: N/A
Study type: Interventional

The research aims to assess the impact on quality of life of surgically maxillary expansion in adult patients followed for obstructive sleep apnea syndrome.

NCT ID: NCT04613414 Recruiting - Clinical trials for Obstructive Sleep Apnea

Evaluation of an Early Management Strategy for Obstructive Sleep Apnea

Start date: June 24, 2022
Phase: N/A
Study type: Interventional

The primary objective of this study is to evaluate the effect of more timely care for obstructive sleep apnea (OSA) on adherence to positive airway pressure (PAP) therapy at three months after treatment initiation. The secondary objectives are to determine if earlier care improves the treatment effect of PAP on patient reported sleepiness, quality of life and patient satisfaction. We will also evaluate the impact of shorter wait times on patient engagement in therapy by assessing initial acceptance of PAP therapy, patient activation and self-efficacy with respect to OSA treatment. The study hypothesis is that the early management strategy will be superior to usual care with respect to the primary outcome of PAP adherence at three months.

NCT ID: NCT04612114 Completed - Clinical trials for Obstructive Sleep Apnea

Pulse Oximeter for Sleep Evaluation

ROSA
Start date: July 21, 2020
Phase:
Study type: Observational

The investigators will conduct this study to validate Belun Ring for sleep assessment. The investigators will compare Belun Ring data collection and overnight in-lab polysomnography (PSG) measures of SDB and sleep architecture in adults with OSA symptoms. The investigators propose to recruit a total of 40 participants with symptoms of obstructive sleep apnea. The investigators will i) validate the overall accuracy, sensitivity and specificity of Belun Ring to assess SDB and sleep architecture, using PSG analysis as a gold standard.

NCT ID: NCT04611750 Completed - Clinical trials for Sleep Disordered Breathing

Pharmacological Intervention for Symptomatic Mild Sleep Disordered Breathing

Start date: December 2, 2020
Phase: Phase 2
Study type: Interventional

Currently, there is no pharmacological intervention for mild symptomatic obstructive sleep disordered breathing (SDB) in the form of loud habitual snoring, inspiratory flow limitation (i.e. upper airway resistance syndrome), or mild sleep apnea. Here the investigators study the effect on SDB of stimulating pharyngeal muscles during sleep with AD036. The key hypothesis of the study is that AD036 is superior to placebo on self-reported and objective measures of SDB severity.